Related Experiment Video
Updated: Mar 11, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
890
The RAS/MAPK Axis Gets Stressed Out
1Department of Discovery Oncology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Molecular Cell
|December 3, 2016
Abstract:
In this issue of Molecular Cell, Ritt et al. (2016) describe a stress-induced checkpoint that effectively suppresses RAS-MAPK signaling. This pathway, activated by agents such as Rigosertib that induce mitotic and oxidative stress, results in JNK-mediated inhibition of RAS-MAPK pathway components SOS and RAF.
Insights
A novel stress-induced checkpoint suppresses RAS-MAPK signaling. This pathway, triggered by agents like Rigosertib, inhibits RAS-MAPK components SOS and RAF via JNK signaling, impacting cell growth and stress response.
Area of Science:
- Cellular biology
- Molecular signaling pathways
- Cancer research
Background:
- RAS-MAPK signaling is crucial for cell proliferation and survival.
- Dysregulation of RAS-MAPK is implicated in various cancers.
- Understanding stress-induced regulation of this pathway is vital.
Purpose of the Study:
- To identify and characterize a stress-induced checkpoint that regulates RAS-MAPK signaling.
- To elucidate the molecular mechanisms underlying this stress response.
- To explore the potential of targeting this pathway with agents like Rigosertib.
Main Methods:
- Investigated cellular responses to mitotic and oxidative stress.
- Utilized molecular biology techniques to analyze protein interactions and signaling cascades.
- Examined the role of c-Jun N-terminal kinase (JNK) in mediating the checkpoint.
Main Results:
- Identified a stress-induced checkpoint that suppresses RAS-MAPK activity.
- Demonstrated that agents like Rigosertib activate this checkpoint.
- Showed JNK-mediated inhibition of RAS-MAPK pathway components SOS and RAF.
Conclusions:
- A novel stress-induced checkpoint effectively suppresses RAS-MAPK signaling.
- This pathway offers a potential therapeutic target for cancers driven by RAS-MAPK.
- Further research into Rigosertib and related compounds is warranted.
Related Concept Videos
01:07MAPK Signaling Cascades
9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
01:19Interactions Between Signaling Pathways
7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
01:22PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
01:20The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
01:42Microtubule Associated Proteins (MAPs)
6.2K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
6.2K